|
Session 122
Poster Abstracts
Adverse Events in Pregnancy
Monday, 1:30 - 3:30 pm
Poster Hall |
| 711 |
Effect of Protease Inhibitor-based ARTon Glucose Tolerance in Pregnancy: ACTG A5084
Jane Hitti*1, J Andersen2, G McComsey3, T Liu2, A Melvin1, A Stek4, J Aberg5, A Hull6, B Alston-Smith7, E Livingston8, and ACTG A5084 Study Team
1Univ of Washington, Seattle, US; 2Harvard Sch of Publ Hlth, Boston, MA, US; 3Case Western Reserve Univ, Cleveland, OH, US; 4David Geffen Sch of Med, Univ of California, Los Angeles Med Ctr, US; 5New York Univ, NY, US; 6Univ of California, San Diego, US; 7NIH, DHHS, Bethesda, MD, US; and 8Duke Univ Sch of Med, Durham, NC, US |
712
 |
Pregnancy Outcomes after Combined ART or Short-course AZT with Single-dose Nevirapine in Thai Women with High and Low CD4 Cell Counts
Nittaya Phanuphak*1, T Apornpong1, S Teeratakulpisarn1, S Limpongsanurak2, W Luesomboon3, A Tangsathapornpong4, C Vitavasiri5, N Singhakowinta6, E Abrams7, P Phanuphak1, and MTCT-Plus Initiative, Bangkok, Thailand
1Thai Red Cross AIDS Res Ctr, Bangkok; 2King Chulalongkorn Memorial Hosp, Bangkok, Thailand; 3Queen Sawangwattana Memorial Hosp, Chonburi, Thailand; 4Thammasat Univ Hosp, Pathumthani, Thailand; 5Police Gen Hosp, Bangkok, Thailand; 6Queen Sirikit hosp, Chonburi, Thailand; and 7Columbia Univ, Mailman Sch of Publ Hlth, New York, NY, US |
| 713 |
Assessing the Risk of Central Nervous System Birth Defects Associated with ART Exposure during Pregnancy
Karen Beckerman*1, H Watts2, D Covington3, B Ross4, A Scheuerle5, D Seekins6, P Clax7, and H Tilson8
1Newark Beth Israel Med Ctr, NJ, US; 2Natl Inst of Child Hlth and Devt, NIH, DHHS, Bethesda, MD, US; 3Charles River Labs Clin Svcs, Wilmington, NC, US; 4Johns Hopkins Univ, Baltimore, MD, US; 5Texas State Birth Defects, Dallas, US; 6Bristol-Myers Squibb, Plainsboro, NJ, US; 7Pfizer, New York, NY, US; and 8Univ of North Carolina at Chapel Hill, US |
|
